New hip implant study aims to reduce dislocation risk in cancer patients

This study looks at two types of hip implants used in total hip replacement for people with metastatic bone disease (cancer that has spread to the hip bone). The goal is to see if a newer implant design (dual mobility) is as good as a standard one (constrained liner) at preventing the hip from popping out of place after surgery. About 146 adults with cancer in the hip bone will take part, and their dislocation rates will be checked at 3 and 6 months after surgery.